Dorsey Wright & Associates Eli Lilly & CO Transaction History

Dorsey Wright & Associates

$408 Million
Q3 2024

A detailed history of Dorsey Wright & Associates transactions in Eli Lilly & CO stock. As of the latest transaction made, Dorsey Wright & Associates holds 18,733 shares of LLY stock, worth $14.9 Million. This represents 4.07% of its overall portfolio holdings.

Number of Shares

18,733

Previous 18,462 1.47%

Holding current value

$14.9 Million

Previous $16.7 Million 0.71%

% of portfolio

4.07%

Previous 4.45%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$772.14 - $960.02 $209,249 - $260,165	271 Added 1.47%	18,733 $16.6 Million
Q2 2024 Aug 15, 2024	BUY	$724.87 - $909.04 $1,449 - $1,818	2 Added 0.01%	18,462 $16.7 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $1.58 Million - $2.12 Million	2,672 Added 16.92%	18,460 $14.4 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $554,600 - $653,801	-1,056 Reduced 6.27%	15,788 $9.2 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $187,355 - $258,298	431 Added 2.63%	16,844 $9.05 Million
Q2 2023 Jul 26, 2023	SELL	$350.74 - $468.98 $146,258 - $195,564	-417 Reduced 2.48%	16,413 $7.7 Million
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $1.72 Million - $2.02 Million	-5,528 Reduced 24.72%	16,830 $5.78 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $4.71 Million - $5.49 Million	14,644 Added 189.84%	22,358 $8.18 Million
Q2 2022 Jul 20, 2022	BUY	$278.73 - $327.27 $1.71 Million - $2.01 Million	6,146 Added 391.96%	7,714 $2.5 Million
Q1 2022 Apr 27, 2022	SELL	$234.69 - $291.66 $1.74 Million - $2.16 Million	-7,418 Reduced 82.55%	1,568 $449,000
Q4 2021 Jan 27, 2022	SELL	$224.85 - $279.04 $70,378 - $87,339	-313 Reduced 3.37%	8,986 $2.48 Million
Q3 2021 Oct 26, 2021	BUY	$221.6 - $272.71 $2.06 Million - $2.54 Million	9,299 New	9,299 $2.15 Million
Q3 2019 Oct 31, 2019	SELL	$106.79 - $116.16 $283,100 - $307,940	-2,651 Closed	0 $0
Q2 2019 Jul 02, 2019	SELL	$110.79 - $129.32 $1.69 Million - $1.97 Million	-15,243 Reduced 85.18%	2,651 $294,000
Q1 2019 Apr 04, 2019	BUY	$111.31 - $131.02 $237,424 - $279,465	2,133 Added 13.53%	17,894 $2.32 Million
Q4 2018 Jan 07, 2019	BUY	$105.9 - $118.64 $1.67 Million - $1.87 Million	15,761 New	15,761 $1.82 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Account

Dorsey Wright & Associates Eli Lilly & CO Transaction History